A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)-Reference-Cited by-同舟云学术

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Published:2018-03 Issue: Volume:270 Page:42-48
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Kayikcioglu Meral,Tokgozoglu Lale,Yilmaz Mehmet,Kaynar Leylagul^ORCID,Aktan Melih,Durmuş Rana Berru,Gokce Cumali,Temizhan Ahmet,Ozcebe Osman Ilhami,Akyol Tulay Karaagac,Okutan Harika,Sag Saim,Gul Ozen Oz,Salcioglu Zafer,Yenercag Mustafa,Altunkeser Bulent B.,Kuku Irfan,Yasar Hamiyet Yilmaz,Kurtoglu Erdal,Kose Melis Demir,Demircioglu Sinan^ORCID,Pekkolay Zafer^ORCID,Ilhan Osman

Funder

Aegerion pharmaceuticals

Amryt Pharmaceuticals

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Homozygous autosomal dominant hypercholesterolaemia in The Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome;Sjouke;Eur. Heart J.,2015

2. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur. Heart J.,2014

3. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment;Rader;J. Clin. Invest.,2003

4. Lipoprotein apheresis: state of the art and novelties;Stefanutti;Atherosclerosis Suppl.,2013

5. Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia;Stefanutti;Cytokine,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current treatments for the management of homozygous familial hypercholesterolaemia: a systematic review and commentary;European Journal of Preventive Cardiology;2024-04-18

2. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia;JAMA Cardiology;2024-04-01

3. Research Progress in the Clinical Treatment of Familial Hypercholesterolemia;Current Medicinal Chemistry;2024-03

4. The Beneficial Effect of Lomitapide on the Cardiovascular System in LDLr−/− Mice with Obesity;Antioxidants;2023-06-16

5. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance;European Heart Journal;2023-05-02